UBS AM
CLOV icon

UBS AM’s Clover Health Investments CLOV Stock Holding History

UBS AM’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.36M Buy
831,748
+149,953
+22% +$509K ﹤0.01% 1673
2026
Q1 		$1.2M Sell
681,795
-98,006
-13% -$213K ﹤0.01% 2275
2025
Q4 		$1.83M Buy
779,801
+115,171
+17% +$315K ﹤0.01% 1917
2025
Q3 		$2.03M Sell
664,630
-437,179
-40% -$1.25M ﹤0.01% 1744
2025
Q2 		$3.07M Buy
1,101,809
+246,545
+29% +$811K ﹤0.01% 1945
2025
Q1 		$3.07M Buy
855,264
+24,807
+3% +$99.6K ﹤0.01% 1803
2024
Q4 		$2.62M Buy
830,457
+394,881
+91% +$1.41M ﹤0.01% 1912
2024
Q3 		$1.23M Buy
+435,576
New +$997K ﹤0.01% 2295
2024
Q2 		– Sell
-141,869
Closed -$113K – 2816
2024
Q1 		$113K Hold
141,869
– – ﹤0.01% 2492
2023
Q4 		$135K Hold
141,869
– – ﹤0.01% 2513
2023
Q3 		$153K Hold
141,869
– – ﹤0.01% 2540
2023
Q2 		$120K Hold
141,869
– – ﹤0.01% 2629
2023
Q1 		$120K Sell
141,869
-203,084
-59% -$222K ﹤0.01% 2629
2022
Q4 		$321K Hold
344,953
– – ﹤0.01% 2320
2022
Q3 		$586K Buy
344,953
+100,391
+41% +$263K ﹤0.01% 2275
2022
Q2 		$523K Sell
244,562
-2,414
-1% -$6.42K ﹤0.01% 2297
2022
Q1 		$877K Hold
246,976
– – ﹤0.01% 2211
2021
Q4 		$919K Buy
246,976
+158,254
+178% +$971K ﹤0.01% 2256
2021
Q3 		$656K Hold
88,722
– – ﹤0.01% 2377
2021
Q2 		$1.18M Buy
+88,722
New +$871K ﹤0.01% 2122

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS AM's CLOV Position: Q2 2026 in Review

UBS AM increased its Clover Health Investments (CLOV) stake by 22% in Q2 2026, buying an estimated $509K and bringing the position to 831,748 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

UBS AM first reported a position in CLOV in Q2 2021 and has held it in 20 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • UBS AM held 831,748 shares of Clover Health Investments worth $4.36M as of Q2 2026.
  • UBS AM bought 149,953 Clover Health Investments shares in Q2 2026, an estimated $509K.
  • Clover Health Investments made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1673 holding.
  • UBS AM first reported a position in Clover Health Investments in Q2 2021 and has held it in 20 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.